Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jan 31, 2018 9:20:22 GMT -5
is a decent resource for stock investors. I will however question their unbelievably approach to sanitize POV that dont match theirs or the author's. How is it that comments defending MNKD and investor's long status get removed while the trash from Spencer's kool aid drinkers get the run of the asylum? If I posted anything the slighest bit "slanderous" my post was quickly removed. A negative comment gets a reply from author and isnt removed. Can only conclude SA has a short position to protect. And recommend that all members of this board treat SA like the disease riden leper it is, avoid at all costs! Dont need the plaque!
|
|
|
Post by derek2 on Jan 31, 2018 16:55:30 GMT -5
|
|
|
Post by mnkdfann on Jan 31, 2018 17:10:20 GMT -5
If I posted anything the slighest bit "slanderous" my post was quickly removed. A negative comment gets a reply from author and isnt removed. There is also a huge difference between making a slanderous comment and a negative differing opinion. I'm constantly surprised how many posters don't seem to understand that.
|
|
|
Post by whale1r1 on Feb 1, 2018 23:40:14 GMT -5
Spencer,
Your report which I my opinion is very clear that "United Therapeutics is pretty much the only game in town" fails to take into account the other big players who may show interest in Mannkind. Specifically Novartis (Pain Medication) and GSK (PAH)..Now if we look at the MNKD Board of Directors -they include 2 members who previously held senior management at both GSK (CMO) and Novartis. Don't be surprised if MNKD utilizes these relationships to help get a deal done.
|
|
|
Post by dreamboatcruise on Feb 2, 2018 4:02:48 GMT -5
Spencer, Your report which I my opinion is very clear that "United Therapeutics is pretty much the only game in town" fails to take into account the other big players who may show interest in Mannkind. Specifically Novartis (Pain Medication) and GSK (PAH)..Now if we look at the MNKD Board of Directors -they include 2 members who previously held senior management at both GSK (CMO) and Novartis. Don't be surprised if MNKD utilizes these relationships to help get a deal done. May is the operative word. If only every "may" was a should or shall.
|
|
|
Post by derek2 on Feb 2, 2018 6:41:58 GMT -5
Spencer, Your report which I my opinion is very clear that "United Therapeutics is pretty much the only game in town" fails to take into account the other big players who may show interest in Mannkind. Specifically Novartis (Pain Medication) and GSK (PAH)..Now if we look at the MNKD Board of Directors -they include 2 members who previously held senior management at both GSK (CMO) and Novartis. Don't be surprised if MNKD utilizes these relationships to help get a deal done. May is the operative word. If only every "may" was a should or shall. Sounds like you have experience with requirements. My sympathy and empathy to you, DBC.
|
|